New research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from returning ...
The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients ...
Black women experience advanced diagnoses 55% more often than white women and are more likely to die from the disease, the ...
GlobalData on MSN22h
SABCS: Pfizer’s IBRANCE combo improves PFS in breast cancer studyHealthcare giant Pfizer’s IBRANCE (palbociclib) as a combination therapy has improved progression-free survival from a Phase ...
Supporting your health & well-being at every stage of your breast cancer journey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback